UCFA
TRIB

United Capital Financial Advisors’s Trinity Biotech TRIB Stock Holding History

United Capital Financial Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,673
Closed -$5.3M – 1323
2016
Q3 		$5.3M Sell
2,673
-15
-0.6% -$28K 0.05% 371
2016
Q2 		$4.44M Sell
2,688
-7
-0.3% -$11.8K 0.05% 385
2016
Q1 		$4.71M Sell
2,695
-63
-2% -$100K 0.05% 346
2015
Q4 		$4.87M Sell
2,758
-246
-8% -$436K 0.06% 334
2015
Q3 		$5.16M Buy
3,004
+424
+16% +$1.02M 0.06% 316
2015
Q2 		$6.99M Buy
2,580
+402
+18% +$1.04M 0.08% 280
2015
Q1 		$5.48M Buy
2,178
+382
+21% +$1.06M 0.07% 314
2014
Q4 		$4.72M Buy
1,796
+483
+37% +$1.25M 0.07% 263
2014
Q3 		$3.49M Buy
1,313
+139
+12% +$452K 0.06% 311
2014
Q2 		$4.05M Buy
1,174
+254
+28% +$903K 0.08% 268
2014
Q1 		$3.34M Sell
920
-58
-6% -$228K 0.07% 273
2013
Q4 		$3.69M Buy
+978
New +$3.52M 0.13% 171
2013
Q3 		– Sell
-743
Closed -$1.88M – 742
2013
Q2 		$1.88M Buy
+743
New +$1.85M 0.05% 318

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

United Capital Financial Advisors's TRIB Position: Q4 2016 in Review

United Capital Financial Advisors sold out of Trinity Biotech (TRIB) in Q4 2016, closing a stake of 2,673 shares — an estimated $5.3M sold.

United Capital Financial Advisors first reported a position in TRIB in Q2 2013 and held it in 13 quarters. The position peaked at $6.99M in Q2 2015. 71 funds tracked by Wall St. Rank hold TRIB as of Q4 2016.

  • United Capital Financial Advisors reported no remaining Trinity Biotech position as of Q4 2016 after selling out during the quarter.
  • United Capital Financial Advisors sold 2,673 Trinity Biotech shares in Q4 2016, an estimated $5.3M.
  • United Capital Financial Advisors first reported a position in Trinity Biotech in Q2 2013 and held it in 13 quarters.
  • United Capital Financial Advisors's Trinity Biotech position peaked at $6.99M in Q2 2015.
  • 71 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2016.

Based on United Capital Financial Advisors's 13F filing for Q4 2016, filed 15 Feb 2017.